These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26818877)

  • 1. The Role of Anionic Polysaccharides in the Preparation of Nanomedicines with Anticancer Applications.
    Martínez AM; Benito M; Pérez E; María Teijón J; Dolores Blanco M
    Curr Pharm Des; 2016; 22(22):3364-79. PubMed ID: 26818877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysaccharides based nanomaterials for targeted anti-cancer drug delivery.
    Dheer D; Arora D; Jaglan S; Rawal RK; Shankar R
    J Drug Target; 2017 Jan; 25(1):1-16. PubMed ID: 27030377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers.
    Ranjbari J; Mokhtarzadeh A; Alibakhshi A; Tabarzad M; Hejazi M; Ramezani M
    Curr Pharm Des; 2018 Feb; 23(39):6019-6032. PubMed ID: 28482782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Overview of Antitumour Activity of Polysaccharides.
    Jin H; Li M; Tian F; Yu F; Zhao W
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Nanocarriers for Anticancer Drugs Delivery.
    Ali I; Lone MN; Suhail M; Mukhtar SD; Asnin L
    Curr Med Chem; 2016; 23(20):2159-87. PubMed ID: 27048343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine: de novo design of nanodrugs.
    Yang Z; Kang SG; Zhou R
    Nanoscale; 2014 Jan; 6(2):663-77. PubMed ID: 24305636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysaccharides as nanocarriers for therapeutic applications.
    Singh D; Han SS; Shin EJ
    J Biomed Nanotechnol; 2014 Sep; 10(9):2149-72. PubMed ID: 25992452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lignin, lipid, protein, hyaluronic acid, starch, cellulose, gum, pectin, alginate and chitosan-based nanomaterials for cancer nanotherapy: Challenges and opportunities.
    Carrion CC; Nasrollahzadeh M; Sajjadi M; Jaleh B; Soufi GJ; Iravani S
    Int J Biol Macromol; 2021 May; 178():193-228. PubMed ID: 33631269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysaccharide-based nucleic acid nanoformulations.
    Raemdonck K; Martens TF; Braeckmans K; Demeester J; De Smedt SC
    Adv Drug Deliv Rev; 2013 Aug; 65(9):1123-47. PubMed ID: 23680381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination antitumor therapy with targeted dual-nanomedicines.
    Dai W; Wang X; Song G; Liu T; He B; Zhang H; Wang X; Zhang Q
    Adv Drug Deliv Rev; 2017 Jun; 115():23-45. PubMed ID: 28285944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarriers overcoming biological barriers induced by multidrug resistance of chemotherapeutics in 2D and 3D cancer models.
    Petrikaite V; D'Avanzo N; Celia C; Fresta M
    Drug Resist Updat; 2023 May; 68():100956. PubMed ID: 36958083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer nanomedicines: so many papers and so few drugs!
    Venditto VJ; Szoka FC
    Adv Drug Deliv Rev; 2013 Jan; 65(1):80-8. PubMed ID: 23036224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Assembled Nanocarriers Based on Amphiphilic Natural Polymers for Anti- Cancer Drug Delivery Applications.
    Sabra S; Abdelmoneem M; Abdelwakil M; Mabrouk MT; Anwar D; Mohamed R; Khattab S; Bekhit A; Elkhodairy K; Freag M; Elzoghby A
    Curr Pharm Des; 2017; 23(35):5213-5229. PubMed ID: 28552068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saccharides, oligosaccharides, and polysaccharides nanoparticles for biomedical applications.
    Seidi F; Jenjob R; Phakkeeree T; Crespy D
    J Control Release; 2018 Aug; 284():188-212. PubMed ID: 29940204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship.
    Bhise K; Sau S; Alsaab H; Kashaw SK; Tekade RK; Iyer AK
    Ther Deliv; 2017 Nov; 8(11):1003-1018. PubMed ID: 29061101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.
    Cadete A; Alonso MJ
    Nanomedicine (Lond); 2016 Sep; 11(17):2341-57. PubMed ID: 27526874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines.
    Greco F; Vicent MJ
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1203-13. PubMed ID: 19699247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production, characterization and application of nanocarriers made of polysaccharides, proteins, bio-polyesters and other biopolymers: A review.
    Samrot AV; Sean TC; Kudaiyappan T; Bisyarah U; Mirarmandi A; Faradjeva E; Abubakar A; Ali HH; Angalene JLA; Suresh Kumar S
    Int J Biol Macromol; 2020 Dec; 165(Pt B):3088-3105. PubMed ID: 33098896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.